Azimuth Capital Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
$15M Sell
182,988
-1,531
-0.8% -$121K 0.64% 51
2021
Q4
$14.1M Sell
184,519
-4,642
-2% -$370K 0.57% 66
2021
Q3
$14.2M Buy
189,161
+565
+0.3% +$43K 0.61% 57
2021
Q2
$14.7M Sell
188,596
-4,658
-2% -$346K 0.63% 53
2021
Q1
$14.2M Sell
193,254
-691
-0.4% -$51K 0.67% 47
2020
Q4
$15.1M Sell
193,945
-1,153
-0.6% -$88.2K 0.75% 40
2020
Q3
$15.4M Sell
195,098
-501
-0.3% -$39.2K 0.91% 27
2020
Q2
$14.4M Sell
195,599
-7,822
-4% -$589K 0.92% 32
2020
Q1
$14.9M Sell
203,421
-4,483
-2% -$352K 1.12% 19
2019
Q4
$18M Sell
207,904
-3,319
-2% -$273K 1.1% 14
2019
Q3
$17M Sell
211,223
-4,889
-2% -$392K 1.11% 15
2019
Q2
$17.3M Sell
216,112
-6,627
-3% -$507K 1.15% 15
2019
Q1
$17.7M Sell
222,739
-9,873
-4% -$738K 1.19% 14
2018
Q4
$17M Sell
232,612
-5,609
-2% -$396K 1.3% 10
2018
Q3
$16.1M Sell
238,221
-1,160
-0.5% -$73.9K 1.08% 18
2018
Q2
$13.9M Sell
239,381
-4,829
-2% -$272K 1% 24
2018
Q1
$12.7M Buy
244,210
+368
+0.2% +$19.9K 0.93% 28
2017
Q4
$13.1M Sell
243,842
-12,265
-5% -$680K 0.95% 24
2017
Q3
$15.6M Buy
256,107
+1,679
+0.7% +$102K 1.17% 12
2017
Q2
$15.6M Buy
254,428
+10
+0% +$609 1.22% 10
2017
Q1
$15.4M Buy
254,418
+70
+0% +$4.25K 1.24% 12
2016
Q4
$14.3M Sell
254,348
-1,289
-0.5% -$75.4K 1.22% 12
2016
Q3
$15.2M Buy
255,637
+649
+0.3% +$38K 1.33% 9
2016
Q2
$14M Sell
254,988
-412
-0.2% -$21.9K 1.25% 11
2016
Q1
$12.9M Buy
255,400
+4,248
+2% +$208K 1.23% 12
2015
Q4
$12.7M Sell
251,152
-686
-0.3% -$34.6K 1.24% 13
2015
Q3
$11.9M Buy
251,838
+1,999
+0.8% +$106K 1.24% 13
2015
Q2
$13.6M Sell
249,839
-2,410
-1% -$135K 1.32% 11
2015
Q1
$13.8M Buy
252,249
+1,335
+0.5% +$75.6K 1.34% 11
2014
Q4
$13.6M Sell
250,914
-2,498
-1% -$139K 1.4% 9
2014
Q3
$14.3M Sell
253,412
-2,786
-1% -$156K 1.57% 8
2014
Q2
$14.1M Sell
256,198
-40,049
-14% -$2.18M 1.58% 8
2014
Q1
$16M Sell
296,247
-25,221
-8% -$1.31M 1.94% 4
2013
Q4
$15.4M Buy
321,468
+29,136
+10% +$1.33M 1.83% 6
2013
Q3
$13.3M Buy
292,332
+93,095
+47% +$4.25M 1.83% 6
2013
Q2
$8.83M Buy
+199,237
New +$8.9M 1.56% 8

Other funds holding MRK

Azimuth Capital Management's MRK Position: Q1 2022 in Review

Azimuth Capital Management reduced its Merck (MRK) stake by 0.83% in Q1 2022, selling an estimated $121K and leaving 182,988 shares worth $15M. The position accounts for 0.64% of the portfolio, ranked #51.

Azimuth Capital Management first reported a position in MRK in Q2 2013 and has held it in 36 quarters since. The position peaked at $18M in Q4 2019. 2,952 funds tracked by Wall St. Rank hold MRK as of Q1 2022.

  • Azimuth Capital Management held 182,988 shares of Merck worth $15M as of Q1 2022.
  • Azimuth Capital Management sold 1,531 Merck shares in Q1 2022, an estimated $121K.
  • Merck made up 0.64% of Azimuth Capital Management's portfolio in Q1 2022, its #51 holding.
  • Azimuth Capital Management first reported a position in Merck in Q2 2013 and has held it in 36 quarters since.
  • Azimuth Capital Management's Merck position peaked at $18M in Q4 2019.
  • 2,952 funds tracked by Wall St. Rank held Merck as of Q1 2022.

Based on Azimuth Capital Management's 13F filing for Q1 2022, filed 13 May 2022.